VEGFA and age-related macular degeneration: In the field of ophthalmology, one of the major issues was to deal with the great number of exudative neovascular age-related macular degeneration (nAMD) patients that require monthly intravitreal injections (IVIs) of anti-vascular endothelial growth factor (VEGF) agents [4, 5].